0
Article ? AI-assigned paper type based on the abstract. Classification may not be perfect — flag errors using the feedback button. Tier 2 ? Original research — experimental, observational, or case-control study. Direct primary evidence. Environmental Sources Human Health Effects Policy & Risk Remediation Reproductive & Development Sign in to save

The Human Plastiphere:A Bioparticulate System ChallengingMicroplastic Risk Assessment and Governance

Figshare 2025 Score: 48 ? 0–100 AI score estimating relevance to the microplastics field. Papers below 30 are filtered from public browse.
V. C. Shruti (22349916), Gurusamy Kutralam-Muniasamy (22349919)

Summary

Drawing on 90 clinical studies from 2016–2025, researchers defined the 'human plastiphere' — the system of non-endogenous plastic particles that accumulate, distribute, and interact with human tissues — and proposed a framework for assessing its health risks. The review mapped MP accumulation in over a dozen tissue types and identified mechanisms of cellular and organ-level harm.

The infiltration of microplastics (MPs) into human tissues represents a paradigm shift in environmental health, transforming external pollution into internal biological integration. Drawing on 90 clinical studies (2016–2025), we define the human plastiphere as a bioparticulate system composed of nonendogenous plastic particles that accumulate, distribute, and interact with host tissues. This system displays key biological features: persistence (decade-scale tissue retention), organized distribution (organotropism across 63 human biological compartments), and active biological engagement (e.g., cardiovascular, reproductive, and metabolic interference). We identify eight unresolved paradoxesranging from size-defying barrier penetration to absent toxicity thresholdsthat highlight critical gaps in synthetic particle biology. The plastiphere challenges conventional toxicology by showing that MPs: (1) follow selective biological rules (e.g., vascular trafficking) while violating others (e.g., phagocytic clearance), and (2) form a measurable, transgenerational burden with escalating health risks as plastic production continues to rise. To address this emerging bioparticulate phenomenon, we propose three urgent actions: harmonized detection protocols, polymer-specific safety thresholds, and source-targeted policy interventions. The plastiphere, both as a biological system and a conceptual framework, offers a roadmap for advancing science from descriptive detection to health-relevant, mechanistically grounded, and policy-actionable solutions.

Sign in to start a discussion.

More Papers Like This

Article Tier 2

The Human Plastiphere: A Bioparticulate System Challenging Microplastic Risk Assessment and Governance

This paper introduces the concept of the "human plastiphere," a system of plastic particles that accumulate and persist in human tissues across 63 different body compartments, based on a review of 90 clinical studies. The authors identify eight unresolved scientific puzzles, including how tiny particles cross biological barriers they should not be able to penetrate, and the absence of any known safe threshold for exposure. The framework calls for standardized detection methods and polymer-specific safety limits to better protect human health as plastic production continues to rise.

Article Tier 2

Unraveling the micro- and nanoplastic predicament: A human-centric insight

This review summarizes what is currently known about micro- and nanoplastic exposure in humans, covering how particles circulate in the environment and accumulate in over 15 different human organs and tissues. The authors analyzed data from 91 toxicity studies and evaluated whether the plastic types and sizes used in experiments reflect real-world human exposure. The review highlights that while evidence of human plastic accumulation is growing, more research with environmentally realistic conditions is needed to truly understand health risks.

Meta Analysis Tier 1

Systemic Accumulation and Distribution of Micro- and Nanoplastics in Human Tissues and Their Impact on Health: A Systematic Review

This systematic review synthesizes human evidence on the presence of micro- and nanoplastics in body tissues and fluids, including blood, lungs, placenta, breast milk, and liver. The research confirms that plastic particles can cross biological barriers and accumulate in multiple organ systems. While the long-term health effects are still being studied, the widespread presence of plastics inside the human body raises significant health concerns.

Article Tier 2

Microplastics in Human Tissues: Sources, Distribution, Toxicological Effects, and Health Implications

Researchers reviewed the growing body of evidence that microplastics accumulate in human tissues — including lung, blood, placenta, breast milk, and heart tissue — where they can trigger inflammation, oxidative stress, and cell death. The review highlights urgent knowledge gaps around how plastic particles move through the body and what their long-term health effects may be.

Article Tier 2

The distribution and total burden of microplastics in the human body

This review assessed current knowledge on the distribution and total body burden of nano- and microplastic particles in humans, synthesizing data from external exposure models and internal tissue measurements. The authors identified major uncertainties in estimating total body burden and called for interdisciplinary studies combining exposure modeling with tissue detection to improve risk assessment for microplastics in healthcare.

Share this paper